An early phase 2 study with XELODA™ (capecitabine) in patients with metastatic breast cancer

被引：0
|
作者：
Saeki, T
Takashima, S
Terashima, M
Tabei, T
Enomoto, K
Tominaga, T
Kimura, T
Miura, S
Koyama, H
Konishi, Y
Oka, T
Naito, Y
Sonoo, H
Toge, T
Dohi, K
Nomizu, T
Taguchi, T
机构：
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
594
引用
收藏
页码：155 / 155
页数：1
相关论文
共 50 条
  • [41] A phase II trial of capecitabine (Xeloda®) in recurrent ovarian cancer
    P A Vasey
    L McMahon
    J Paul
    N Reed
    S B Kaye
    British Journal of Cancer, 2003, 89 : 1843 - 1848
  • [42] A phase I study of capecitabine and a modulatory dose of irinotecan in metastatic breast cancer
    O'Connor, T.
    Rustum, Y.
    Levine, E.
    Creaven, P.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (01) : 125 - 131
  • [43] A phase I study of capecitabine and a modulatory dose of irinotecan in metastatic breast cancer
    T. O’Connor
    Y. Rustum
    E. Levine
    P. Creaven
    Cancer Chemotherapy and Pharmacology, 2008, 61 : 125 - 131
  • [44] CAPECITABINE AND GEMCITABINE IN METASTATIC BREAST CANCER: A PHASE I-II STUDY
    Giannessi, P. G.
    Di Marsico, R.
    Martella, F.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2004, 15 : 25 - 25
  • [45] Phase II study of gemcitabine and capecitabine in patients with metastatic breast cancer pretreated with anthracyclines and taxanes.
    Ahn, JH
    Kim, SB
    Lee, JS
    Kang, YK
    Kim, WK
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 101S - 101S
  • [46] A phase II study of capecitabine and weekly docetaxel combination chemotherapy in patients with metastatic breast cancer.
    Puglisi, F
    Scalone, S
    Minisini, AM
    Mansutti, M
    Crivellari, D
    Buonadonna, A
    Zanetti, M
    Ermacora, P
    Piga, A
    Veronesi, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 78S - 78S
  • [47] Extended phase I study of capecitabine in combination with vinorelbine in pretreated patients with metastatic breast cancer.
    Welt, A
    Von Minckwitz, G
    Borquez, D
    Oberhoff, C
    Kaufmann, M
    Seeber, S
    Vanhoefer, U
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S90 - S90
  • [48] Oral combination chemotherapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: phase II study.
    Tanaka, M.
    Tamura, K.
    Anan, K.
    Ohno, S.
    Nishimura, R.
    Yamamoto, Y.
    Masuda, N.
    Mitsuyama, S.
    CANCER RESEARCH, 2009, 69 (02) : 383S - 384S
  • [49] Phase II study of irinotecan plus capecitabine in patients with anthracycline and taxane pretreated metastatic breast cancer
    Lee, K. S.
    Ro, J.
    Park, I. H.
    Kim, E. A.
    Nam, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [50] Phase II study of an all-oral combination of vinorelbine with capecitabine in patients with metastatic breast cancer
    Nole, Franco
    Crivellari, D.
    Mattioli, R.
    Pinotti, G.
    Foa, P.
    Verri, E.
    Fougeray, R.
    Brandely, M.
    Goldhirsch, A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (04) : 673 - 680
12345